Understanding how certain proteins help HPV infect cells
Elucidating the role of dynein-cargo adaptor proteins in Human papillomavirus infection
This study is looking at how certain proteins help the HPV virus get into human cells and reach the part of the cell where it can cause infection, with the hope that this could lead to new treatments for HPV.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10894947 on NIH RePORTER |
What this research studies
This research investigates the role of specific proteins, known as dynein-cargo adaptor proteins, in the process of Human papillomavirus (HPV) infection. By examining how HPV enters and moves within human cells, the study aims to uncover the mechanisms that allow the virus to reach the nucleus and cause infection. The researchers will employ various biochemical and genetic techniques to explore how these proteins facilitate the transport of HPV through different cellular compartments. This knowledge could lead to the development of new antiviral therapies against HPV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are infected with HPV or are at high risk for HPV-related cancers.
Not a fit: Patients who are not infected with HPV or who have already received effective treatment for HPV-related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective antiviral treatments for HPV infections.
How similar studies have performed: Other research has shown promise in understanding viral infections through similar cellular mechanism investigations, indicating potential for success in this area.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Speckhart, Kaitlyn Noel — University of Michigan at Ann Arbor
- Study coordinator: Speckhart, Kaitlyn Noel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.